Treating NIDDM with RXR agonists
First Claim
Patent Images
1. A method of treating hypertriglyceridemia in a host suffering therefrom, comprising the step of administering to said host a pharmaceutically effective amount of an RXR agonist.
1 Assignment
0 Petitions
Accused Products
Abstract
This invention relates to methods and compositions for the treatment of non-insulin-dependent diabetes mellitus using an RXR agonist alone or in combination with a PPARγ agonist such as a thiazolidinedione compound.
-
Citations
47 Claims
-
1. A method of treating hypertriglyceridemia in a host suffering therefrom, comprising the step of administering to said host a pharmaceutically effective amount of an RXR agonist.
- 2. A method of increasing the level of HDL cholesterol in a host, comprising the step of administering to said host a pharmaceutically effective amount of an RXR specific agonist.
-
3. A method of preventing hypertriglyceridemia in a host, comprising the step of administering to said host a pharmaceutically effective amount of an RXR agonist.
- 4. A method of treating cardiovascular disease in a host suffering therefrom, comprising the step of administering to said host a pharmaceutically effective amount of an RXR specific agonist.
- 5. A method of preventing cardiovascular disease in a host, comprising the step of administering to said host a pharmaceutically effective amount of an RXR specific agonist.
Specification